Top

Open Access 20-11-2023 | Heart Transplantation | Letter to the Editors

Unique 40-year survival after heart transplantation with normal graft function and spontaneous operational tolerance

Authors: Wolfgang von Scheidt, Bruno Reichart, Bruno Meiser, Moritz von Scheidt, Partho Sen, Florian Schwarz, Eva Harmel, Frank M. Bengel, Andrea Dick, Peter Ueberfuhr, Hermann Reichenspurner, Elmar Jaeckel, Reinhard Schwinzer, Christian Hagl

Published in: Clinical Research in Cardiology

Graphical abstract

Unique 40-year survival after heart transplantation with normal graft function and spontaneous operational tolerance.

Available only for authorised users

Stehlik J, Kobashigawa J, Hunt SA, Reichenspurner H, Kirklin JK (2018) Honoring 50 years of clinical heart transplantation in circulation: in-depth state-of-the-art review. Circulation 137:71–87. https://doi.org/10.1161/CIRCULATIONAHA.117.029753 CrossRefPubMed

Khush KK, Cherikh WS, Chambers DC et al (2019) The International thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult heart transplantation report - 2019; focus theme: donor and recipient size match. J Heart Lung Transplant 38:1056–1066. https://doi.org/10.1016/j.healun.2019.08.004 CrossRefPubMedPubMedCentral

Hess NR, Seese LM, Mathier MA et al (2021) Twenty-year survival following orthotopic heart transplantation in the United States. J Card Surg 36:643–650. https://doi.org/10.1111/jocs.15234 CrossRefPubMed

Kleid L, Walter J, Vorstandlechner M et al (2023) Predictive value of molecular matching tools for the development of donor specific HLA-antibodies in patients undergoing lung transplantation. HLA. https://doi.org/10.1111/tan.15068 CrossRefPubMed

Germany DFSOo. Periods Mortality Tables For Germany. https://www.statistischebibliothek.de/mir/servlets/MCRFileNodeServlet/DEHeft_derivate_00042902/5126202039004.pdf. Accessed 5 May 2023

Banner NR, Yacoub MH (2004) Cyclosporine in thoracic organ transplantation. Transplant Proc 36:302S-308S. https://doi.org/10.1016/j.transproceed.2004.01.031 CrossRefPubMed

Baran DA, Kapoor S, Grewal J, Andries G, Camacho M (2023) Long term follow-up of the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial. J Heart Lung Transplant 42:838–845. https://doi.org/10.1016/j.healun.2023.01.016 CrossRefPubMed

Velleca A, Shullo MA, Dhital K et al (2023) The international society for heart and lung transplantation (ISHLT) guidelines for the care of heart transplant recipients. J Heart Lung Transplant 42:e1–e141. https://doi.org/10.1016/j.healun.2022.10.015 CrossRefPubMed

Tuzcu EM, Kapadia SR, Sachar R et al (2005) Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol 45:1538–1542. https://doi.org/10.1016/j.jacc.2004.12.076 CrossRefPubMed

10.

Kubrich M, Petrakopoulou P, Kofler S et al (2008) Impact of coronary endothelial dysfunction on adverse long-term outcome after heart transplantation. Transplantation 85:1580–1587. https://doi.org/10.1097/TP.0b013e318170b4cd CrossRefPubMed

11.

Kobashigawa J, Wener L, Johnson J et al (2000) Longitudinal study of vascular remodeling in coronary arteries after heart transplantation. J Heart Lung Transplant 19:546–550. https://doi.org/10.1016/s1053-2498(00)00100-5 CrossRefPubMed

12.

Mitchell RN, Libby P (2007) Vascular remodeling in transplant vasculopathy. Circ Res 100:967–978. https://doi.org/10.1161/01.RES.0000261982.76892.09 CrossRefPubMed

13.

Olymbios M, Kwiecinski J, Berman DS, Kobashigawa JA (2018) Imaging in heart transplant patients. JACC Cardiovasc Imaging 11:1514–1530. https://doi.org/10.1016/j.jcmg.2018.06.019 CrossRefPubMed

14.

Mehra MR, Crespo-Leiro MG, Dipchand A et al (2010) International society for heart and lung transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant 29:717–727. https://doi.org/10.1016/j.healun.2010.05.017 CrossRefPubMed

15.

Mirabet S, Garcia-Osuna A, Garcia de Frutos P et al (2018) High-sensitivity troponin t and soluble form of AXL as Long-term prognostic biomarkers after heart transplantation. Dis Markers 2018:6243529. https://doi.org/10.1155/2018/6243529 CrossRefPubMedPubMedCentral

16.

Bengel FM, Ueberfuhr P, Schiepel N et al (2001) Effect of sympathetic reinnervation on cardiac performance after heart transplantation. N Engl J Med 345:731–738. https://doi.org/10.1056/NEJMoa010519 CrossRefPubMed

17.

Bengel FM, Ueberfuhr P, Hesse T et al (2002) Clinical determinants of ventricular sympathetic reinnervation after orthotopic heart transplantation. Circulation 106:831–835. https://doi.org/10.1161/01.cir.0000025631.68522.9d CrossRefPubMed

18.

Schwaiblmair M, von Scheidt W, Uberfuhr P et al (1999) Functional significance of cardiac reinnervation in heart transplant recipients. J Heart Lung Transplant 18:838–845. https://doi.org/10.1016/s1053-2498(99)00048-0 CrossRefPubMed

19.

von Scheidt W, Bohm M, Schneider B et al (1992) Isolated presynaptic inotropic beta-adrenergic supersensitivity of the transplanted denervated human heart in vivo. Circulation 85:1056–1063. https://doi.org/10.1161/01.cir.85.3.1056 CrossRef

20.

Costanzo MR, Dipchand A, Starling R et al (2010) The international society of heart and lung transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant 29:914–956. https://doi.org/10.1016/j.healun.2010.05.034 CrossRefPubMed

21.

Battikha CS, Selevany I, Kim P (2020) Advances and new insights in post-transplant care: from sequencing to imaging. Curr Treat Options Cardiovasc Med 22(10):32. https://doi.org/10.1007/s11936-020-00828-8.Report#:32 CrossRef

22.

Bedford A, Jervis S, Worthington J, Lowe M, Poulton K (2022) Human leukocyte antigen epitope mismatch loads and the development of de novo donor-specific antibodies in cardiothoracic organ transplantation. Int J Immunogenet 49:30–38. https://doi.org/10.1111/iji.12563 CrossRefPubMed

23.

Lefaucheur C, Louis K, Morris AB et al (2023) Clinical recommendations for posttransplant assessment of anti-HLA (human leukocyte antigen) donor-specific antibodies: a sensitization in transplantation: assessment of risk consensus document. Am J Transplant 23:115–132. https://doi.org/10.1016/j.ajt.2022.11.013 CrossRefPubMed

24.

Jaiswal A, Bell J, DeFilippis EM et al (2023) Assessment and management of allosensitization following heart transplant in adults. J Heart Lung Transplant 42:423–432. https://doi.org/10.1016/j.healun.2022.12.011 CrossRefPubMed

25.

Feng S, Demetris AJ, Spain KM et al (2017) Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R. Hepatology 65:647–660. https://doi.org/10.1002/hep.28681 CrossRefPubMed

26.

Londono MC, Danger R, Giral M et al (2012) A need for biomarkers of operational tolerance in liver and kidney transplantation. Am J Transplant 12:1370–1377. https://doi.org/10.1111/j.1600-6143.2012.04035.x CrossRefPubMed

27.

Newell KA, Adams AB, Turka LA (2018) Biomarkers of operational tolerance following kidney transplantation - The immune tolerance network studies of spontaneously tolerant kidney transplant recipients. Hum Immunol 79:380–387. https://doi.org/10.1016/j.humimm.2018.02.007 CrossRefPubMedPubMedCentral

28.

Cherukuri A, Ding Q, Sharma A, Mohib K, Rothstein DM (2019) Regulatory and effector B cells: a new path toward biomarkers and therapeutic targets to improve transplant outcomes? Clin Lab Med 39:15–29. https://doi.org/10.1016/j.cll.2018.10.011 CrossRefPubMed

29.

Appenzeller-Herzog C, Hartleif S, Vionnet J (2021) Clinical parameters and biomarkers predicting spontaneous operational tolerance after liver transplantation: a scoping review. Am J Transplant 21:3312–3323. https://doi.org/10.1111/ajt.16585 CrossRefPubMed

30.

Niederlova V, Tsyklauri O, Chadimova T, Stepanek O (2021) CD8(+) tregs revisited: a heterogeneous population with different phenotypes and properties. Eur J Immunol 51:512–530. https://doi.org/10.1002/eji.202048614 CrossRefPubMed

31.

Neu SD, Dittel BN (2021) Characterization of definitive regulatory B cell subsets by cell surface phenotype. Funct Context Front Immunol 12:787464. https://doi.org/10.3389/fimmu.2021.787464 CrossRef

32.

Mederacke YS, Nienen M, Jarek M et al (2021) T cell receptor repertoires within liver allografts are different to those in the peripheral blood. J Hepatol 74:1167–1175. https://doi.org/10.1016/j.jhep.2020.12.014 CrossRefPubMed

33.

Geng L, Liu J, Huang J et al (2018) A high frequency of CD8(+)CD28(-) T-suppressor cells contributes to maintaining stable graft function and reducing immunosuppressant dosage after liver transplantation. Int J Med Sci 15:892–899. https://doi.org/10.7150/ijms.24042 CrossRefPubMedPubMedCentral

34.

Liu G, Yu Y, Feng F et al (2020) Human CD8(+)CD28(-) T suppressor cells expanded by common gamma chain (gammac) cytokines retain steady allospecific suppressive capacity in vivo. BMC Immunol 21:23. https://doi.org/10.1186/s12865-020-00354-z CrossRefPubMedPubMedCentral

35.

Colovai AI, Mirza M, Vlad G et al (2003) Regulatory CD8+CD28- T cells in heart transplant recipients. Hum Immunol 64:31–37. https://doi.org/10.1016/s0198-8859(02)00742-5 CrossRefPubMed

36.

Cantisan S, Torre-Cisneros J, Lara R et al (2013) Impact of cytomegalovirus on early immunosenescence of CD8+ T lymphocytes after solid organ transplantation. J Gerontol A Biol Sci Med Sci 68:1–5. https://doi.org/10.1093/gerona/gls130 CrossRefPubMed

Title: Unique 40-year survival after heart transplantation with normal graft function and spontaneous operational tolerance
Authors: Wolfgang von Scheidt
Bruno Reichart
Bruno Meiser
Moritz von Scheidt
Partho Sen
Florian Schwarz
Eva Harmel
Frank M. Bengel
Andrea Dick
Peter Ueberfuhr
Hermann Reichenspurner
Elmar Jaeckel
Reinhard Schwinzer
Christian Hagl
Publication date: 20-11-2023
Publisher: Springer Berlin Heidelberg
Keywords: Heart Transplantation
Heart Transplantation
Heart Transplantation
Heart Transplantation
Heart Transplantation
Published in: Clinical Research in Cardiology
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-023-02341-x

Webinar | 16-05-2023 | 17:30 (CET)

Keynote Webinar | Spotlight on Cardio-Oncology

Watch now

An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.

Prof. Rudolf de Boer

Prof. Lorenz Lehmann

Dr. Teresa Lopéz Fernández

Keynote Webinar | Spotlight on Diet and Diabetes

Springer Medicine

Unique 40-year survival after heart transplantation with normal graft function and spontaneous operational tolerance

Graphical abstract

Keynote Webinar | Spotlight on Cardio-Oncology

Keynote Webinar | Spotlight on Diet and Diabetes

Springer Medicine

Graphical abstract

Please log in to get access to this content

Keynote Webinar | Spotlight on Cardio-Oncology